Investigational Site Number : 1560007

Xuzhou 221006

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Running, not enrolling
• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed